Association of the angiotensin II type i receptor gene 1166 A>C polymorphism with hypertension risk: Evidence from a meta-analysis of 16474 subjects

Hypertension Research

Volumn 33, Issue 11, 2010, Pages 1137-1143

  Niu, Wenquan ^a   Qi, Yue ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

+1166 A>C polymorphism; AT1R; meta analysis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR;

ALLELE; ARTICLE; AUSTRALIA; BRAZIL; CHINESE; COLOMBIA; CROATIA; GENETIC ASSOCIATION; GENETIC RISK; GEOGRAPHY; GERMANY; HUMAN; HYPERTENSION; INHERITANCE; JAPANESE; NETHERLANDS; POLAND; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SYSTEMATIC REVIEW; TAIWAN; TURKEY (REPUBLIC);

ADULT; AGED; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RISK;

EID: 78149323036     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.156     Document Type: Article

References (39)

1. Niu W, Qi Y, Cen W, Cui C, Zhuoma C, Cai D, Zhou W, Qiu C. Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population. Hypertens Res 2007; 30: 1129-1137.
2. Qi Y, Niu W, Zhou W, Hou S, Qiu C. Correlation between angiotensinogen gene polymorphisms and essential hypertension in Chinese population. J Hum Hypertens 2008; 22: 147-150.
3. Weir MR, Henrich WL. Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 block-ers. Curr Opin Nephrol Hypertens 2000; 9: 403-411.
4. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 2006; 103: 17985-17990.
5. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 2007; 282: 24262-24269.
6. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet 2000; 355: 308-311.
7. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182.
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
9. Cohn LD, Becker BJ. How meta-analysis increases statistical power. Psychol Methods 2003; 8: 243-253.
10. Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 1997; 51: 31-34.
11. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 1997; 15: 1385-1388. (Pubitemid 28039564)
12. Liyou N, Davis D, James K, Simons L, Friedlander Y, Simons J, McCallum J, Johnson A. The A1166C mutation in the angiotensin II type I receptor and hypertension in the elderly. Clin Exp Pharmacol Physiol 1999; 26: 525-526.
13. Thomas GN, Young RP, Tomlinson B, Woo KS, Sanderson JE, Critchley JA. Renin-angiotensin-aldosterone system gene polymorphisms and hypertension in Hong Kong Chinese. Clin Exp Hypertens 2000; 22: 87-97.
14. Kato N, Sugiyama T, Morita H, Kurihara H, Furukawa T, Isshiki T, Sato T, Yamori Y, Yazaki Y. Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens 2000; 18: 1025-1032.
15. Dzida G, Sobstyl J, Puzniak A, Golon P, Mosiewicz J, Hanzlik J. Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 genes in essential hypertension in a Polish population. Med Sci Monit 2001; 7: 1236-1241.
16. Jiang Z, Zhao W, Yu F, Xu G. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Chin Med J (Engl) 2001; 114: 1249-1251.
17. Liu Y, Zhuoma C, Shan G, Cui C, Hou S, Qin W, Cai D, Gesang L, Xiao Z, Pingcuo Z, Zheng H, Wu Z, Zhou W, Qiu C. A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations. Hypertens Res 2002; 25: 515-521.
18. Agachan B, Isbir T, Yilmaz H, Akoglu E. Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med 2003; 35: 545-549.
19. Ono K, Mannami T, Baba S, Yasui N, Ogihara T, Iwai N. Lack of association between angiotensin II type 1 receptor gene polymorphism and hypertension in Japanese. Hypertens Res 2003; 26: 131-134. (Pubitemid 36372331)
20. Pamies-Andreu E, Ramirez-Lorca R, Stiefel García-Junco P, Muñiz-Grijalbo O, Vallejo-Maroto I, Garcia Morillo S, Miranda-Guisado ML, Ort́iz JV, Carneado de la Fuente J. Renin-angiotensin-aldosterone system and G-protein beta-3 subunit gene polymorphisms in salt-sensitive essential hypertension. J Hum Hypertens 2003; 17: 187-191.
21. Tsai CT, Fallin D, Chiang FT, Hwang JJ, Lai LP, Hsu KL, Tseng CD, Liau CS, Tseng YZ. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 2003; 41: 9-15.
22. Stanković A, Zivkovic M, Glisić S, Alavantić D. Angiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian population. Clin Chim Acta 2003; 327: 181-185.
23. Sugimoto K, Katsuya T, Ohkubo T, Hozawa A, Yamamoto K, Matsuo A, Rakugi H, Tsuji I, Imai Y, Ogihara T. Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 2004; 27: 551-556.
24. Barbalić M, Skarić-Jurić T, Cambien F, Barbaux S, Poirier O, Turek S, Vrhovski-Hebrang D, Cubrilo-Turek M, Rudan I, Rudan P, Narancić NS. Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Am J Hypertens 2006; 19: 837-842.
25. Freitas SR, Cabello PH, Moura-Neto RS, Dolinsky LC, Bóia MN. Combined analysis of genetic and environmental factors on essential hypertension in a brazilian rural population in the Amazon region. Arq Bras Cardiol 2007; 88: 447-451.
26. van den Born BJ, van Montfrans GA, Uitterlinden AG, Zwinderman AH, Koopmans RP. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens 2007; 25: 2227-2233.
27. Bautista LE, Vargas CI, Oróstegui M, Gamarra G. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics. Hypertens Res 2008; 31: 401-408.
28. Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens 2009; 27: 1384-1391.
29. Jiang X, Sheng H, Li J, Xun P, Cheng Y, Huang J, Xiao H, Zhan Y. Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens 2009; 23: 176-181.
30. Niu WQ, Zhao HY, Zhou L, Dai XX, Wang DY, Cao J, Wang B. Interacting effect of genetic variants of angiotensin II type 1 receptor on susceptibility to essential hypertension in Northern Han Chinese. J Hum Hypertens 2009; 23: 68-71.
31. Nie SJ, Wen-ru T, Bi-feng C, Jin L, Wen Z, Sheng-jun L, Wei-wei L, Hai-jing Y, Chun-jie X. Haplotype-based case-control study of the human AGTR1 gene and essential hypertension in Han Chinese subjects. Clin Biochem 2010; 43: 253-258.
32. Wang JL, Xue L, Hao PP, Xu F, Chen YG, Zhang Y. Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2010; 11: 127-135.
33. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91-99.
34. Munafò MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2004; 20: 439-444.
35. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182.
36. Greene CS, Penrod NM, Williams SM, Moore JH. Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS One 2009; 4: e5639.
37. Ruano-Ravina A, Pérez-Ríos M, Barros-Dios JM. Population-based versus hospital-based controls: are they comparable? Gac Sanit 2008; 22: 609-613.
38. Yu K, Zhang J, Zhang J, Dou C, Gu S, Xie Y, Mao Y, Ji C. Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet 2009; 18: 370-378.
39. Niu WQ, Qi Y, Zhang LT, Qi YX, Wang B, Hou SQ, Zhai XY, Qiu CC. Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J Hum Hypertens 2009; 23: 136-139.